Search research articles
Contact Us
Filters
Showing results (61-70 of 69) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 69 results.
The Journal of Allergy and Clinical Immunology. in Practice
|
May 20, 2024
Nonepithelial Gene Expression Correlates With Symptom Severity in Adults With Eosinophilic Esophagitis
Seung Kim, Netali Ben-Baruch Morgenstern, Kasumi Osonoi, et al.
The Journal of Allergy and Clinical Immunology
|
May 16, 2024
Clinical and molecular correlates of the Index of Severity for Eosinophilic Esophagitis
Hiroki Sato, Evan S Dellon, Seema S Aceves, et al.
The Journal of Allergy and Clinical Immunology
|
November 19, 2019
Molecular, endoscopic, histologic, and circulating biomarker-based diagnosis of eosinophilic gastritis: Multi-site study
Tetsuo Shoda, Ting Wen, Julie M Caldwell, et al.
The American Journal of Gastroenterology
|
January 26, 2022
Prospective Endoscopic Activity Assessment for Eosinophilic Gastritis in a Multisite Cohort
Ikuo Hirano, Margaret H Collins, Eileen King, et al.
The Lancet. Gastroenterology & Hepatology
|
May 7, 2018
Eosinophilic oesophagitis endotype classification by molecular, clinical, and histopathological analyses: a cross-sectional study
Tetsuo Shoda, Ting Wen, Seema S Aceves, et al.
Gastroenterology
|
January 27, 2022
Evaluating Eosinophilic Colitis as a Unique Disease Using Colonic Molecular Profiles: A Multi-Site Study
Tetsuo Shoda, Margaret H Collins, Mark Rochman, et al.
Gastroenterology
|
October 23, 2021
Loss of Endothelial TSPAN12 Promotes Fibrostenotic Eosinophilic Esophagitis via Endothelial Cell-Fibroblast Crosstalk
Tetsuo Shoda, Ting Wen, Julie M Caldwell, et al.
The Lancet. Gastroenterology & Hepatology
|
March 2, 2023
One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial
Kara L Kliewer, Nirmala Gonsalves, Evan S Dellon, et al.
The Lancet. Gastroenterology & Hepatology
|
June 24, 2026
Dupilumab versus placebo in adults and adolescents with eosinophilic gastritis (DEGAS): a double-blind, placebo-controlled, phase 2, multicentre, randomised controlled trial
Nirmala P Gonsalves, Evan S Dellon, Kara L Kliewer, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 69) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 69 results.
The Journal of Allergy and Clinical Immunology. in Practice
|
May 20, 2024
Nonepithelial Gene Expression Correlates With Symptom Severity in Adults With Eosinophilic Esophagitis
Seung Kim, Netali Ben-Baruch Morgenstern, Kasumi Osonoi, et al.
The Journal of Allergy and Clinical Immunology
|
May 16, 2024
Clinical and molecular correlates of the Index of Severity for Eosinophilic Esophagitis
Hiroki Sato, Evan S Dellon, Seema S Aceves, et al.
The Journal of Allergy and Clinical Immunology
|
November 19, 2019
Molecular, endoscopic, histologic, and circulating biomarker-based diagnosis of eosinophilic gastritis: Multi-site study
Tetsuo Shoda, Ting Wen, Julie M Caldwell, et al.
The American Journal of Gastroenterology
|
January 26, 2022
Prospective Endoscopic Activity Assessment for Eosinophilic Gastritis in a Multisite Cohort
Ikuo Hirano, Margaret H Collins, Eileen King, et al.
The Lancet. Gastroenterology & Hepatology
|
May 7, 2018
Eosinophilic oesophagitis endotype classification by molecular, clinical, and histopathological analyses: a cross-sectional study
Tetsuo Shoda, Ting Wen, Seema S Aceves, et al.
Gastroenterology
|
January 27, 2022
Evaluating Eosinophilic Colitis as a Unique Disease Using Colonic Molecular Profiles: A Multi-Site Study
Tetsuo Shoda, Margaret H Collins, Mark Rochman, et al.
Gastroenterology
|
October 23, 2021
Loss of Endothelial TSPAN12 Promotes Fibrostenotic Eosinophilic Esophagitis via Endothelial Cell-Fibroblast Crosstalk
Tetsuo Shoda, Ting Wen, Julie M Caldwell, et al.
The Lancet. Gastroenterology & Hepatology
|
March 2, 2023
One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial
Kara L Kliewer, Nirmala Gonsalves, Evan S Dellon, et al.
The Lancet. Gastroenterology & Hepatology
|
June 24, 2026
Dupilumab versus placebo in adults and adolescents with eosinophilic gastritis (DEGAS): a double-blind, placebo-controlled, phase 2, multicentre, randomised controlled trial
Nirmala P Gonsalves, Evan S Dellon, Kara L Kliewer, et al.
Page
of 7